Subcutaneous infliximab in pediatric inflammatory bowel disease: Sustained remission, predictable pharmacokinetics, and real‐world US implementation
Year: 2026
Type: article
DOI: 10.1002/jpn3.70510
Institutions: Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
Award: G1100867373
OpenAlex ID: W7170052011
